Ilyda SA engages in software development business in Greece. It offers enterprise resource planning systems, such as Business Suite MegaTron ERP; MegaTron Retail System; MegaTron for access control; Dioscourides, a pharmacy application; MegaTron pharma ERP; MegaTron DEYA; LIS Bio-Diagnosis; VitaCard, a consumer card; software development made to order; provision of integrated it systems; and Unilink. The company also provides development and support of ERP Systems; development of software for vertical markets; and development of software to order, as well as provision of integrated information technology systems. It serves industrial and craft, commercial, and service providers, as well as public sector industries. Ilyda SA was founded in 1992 and is headquartered in Athens, Greece.…
What Is Novartis (SWX:NOVN) Gaining From Its PMR Approval And ADC Deal?
Ilyda (ATH: ILYDA) is listed on Athens Exchange, where its shares trade in EUR. It belongs to the Software - Application industry, part of the Technology sector, and reports about 51 employees.
The shares were at 3.940 EUR on 20 November 2026, down 29.1% over 52 weeks. Its 52-week range is 3.740 EUR to 5.560 EUR: the price is 29.1% below the high and 5.3% above the low.
At a market capitalisation of 55.60M EUR, it trades at 9.4 times trailing earnings. The median trailing P/E of its 18 largest Software - Application peers is 33.6, a discount of 72% for ILYDA. It pays a dividend yielding 2.21% (it pays out 38% of its earnings), against a median of 1.36% among the dividend payers in that peer group.
Ilyda reports return on equity of 27.5%, an operating margin of 68.5% and revenue up 15.8% year over year.
It holds more cash than debt, a net cash position of 8.44M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.
No upcoming events tracked.